Avicenna Holdings Limited has been acquired by Juno Health
The shareholders of Avicenna Holdings Limited have sold the business to Juno Health.
Based in the UK, Avicenna comprises 21 pharmacies, as well as a buying group operation serving more than 1,000 independent pharmacies.
Juno Health is a UK-based company that operates a chain of pharmacy stores. The community pharmacies will be integrated into Juno’s existing chain with the buying group continuing to be run by Salim Jetha, Avicenna CEO. It will become the industry-leading buying and support group for independent pharmacies across the UK. Juno has considerable experience in the sector and the combination of Avicenna resources and expertise will support the independent pharmacy sector and improve membership benefits.
Richard Smith, Chairman at Juno Health, said: “Avicenna is a well-established business delivering clear benefits to its members. It is one of the most recognizable brands among independent pharmacists and extremely well respected.”
Oaklins Cavendish, based in the UK, advised the shareholders of Avicenna on the sale of the business to Juno Health.
Talk to the deal team
Related deals
HC Partners has successfully secured debt financing for the acquisition of West Friesland Dakbedekkingen
Dutch private equity firm HC Partners has formed a strategic partnership with West Friesland Dakbedekkingen B.V. (WFD). This marks HC Partners’ entry into the roofing sector, with plans to build a national platform of regional roofing specialists.
Learn moreDanish leader in access control systems has been sold to Vækst-Invest
Unitek, a leading provider of innovative access control systems in Denmark, has been acquired by the Danish private equity firm Vækst-Invest to drive its growth and expansion.
Learn moreGenerali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.
Learn more